Technology Insight: imaging neurodegeneration in Parkinson's disease

被引：0
|
作者：
David J Brooks
机构：
[1] DJ Brooks is Hartnett Professor of Neurology in the Faculty of Medicine at Imperial College,
[2] and Head of the Neurology Group at the Medical Research Council Clinical Sciences Centre at Hammersmith Hospital,undefined
[3] London,undefined
[4] and Head of Neurology,undefined
[5] Medical Diagnostics,undefined
[6] GE Healthcare,undefined
[7] Amersham,undefined
[8] UK.,undefined
来源：
Nature Clinical Practice Neurology | 2008年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Currently, idiopathic Parkinson's disease can only be diagnosed definitively by the demonstration of intracellular Lewy body inclusions on histological specimens of brain tissue—an approach that is impractical in living individuals. In this Review, David Brooks discusses recent advances in noninvasive imaging approaches that are providing important insights into the structural, pathophysiological and pharmacological changes associated with Parkinson's disease, and could have major implications for the future diagnosis and management of this condition.
引用
收藏
页码：267 / 277
页数：10
相关论文
共 50 条
  • [21] The Paths to Neurodegeneration in Genetic Parkinson's Disease
    Abdel-Salam, Omar M. E.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (09) : 1485 - 1512
  • [22] Calpain Mediated Neurodegeneration in Parkinson's disease
    Knaryan, V. H.
    NEUROCHEMICAL JOURNAL, 2023, 17 (04) : 632 - 638
  • [23] Animal models of neurodegeneration in Parkinson's disease
    Earl, C
    Sautter, J
    PARKINSON'S DISEASE, 2002, 1 : 88 - 93
  • [24] Cyclooxygenase and Neuroinflammation in Parkinson's Disease Neurodegeneration
    Bartels, Anna L.
    Leenders, Klaus L.
    CURRENT NEUROPHARMACOLOGY, 2010, 8 (01) : 62 - 68
  • [25] Neurodegeneration and cognition in Parkinson's disease: a review
    Ding, W.
    Ding, L. -J.
    Li, F. -F.
    Han, Y.
    Mu, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (12) : 2275 - 2281
  • [26] Hypothetical mechanisms of neurodegeneration in Parkinson's disease
    Ruberg, M
    FranceLanord, V
    Lambeng, N
    Nguyen, TT
    Cerqueira, E
    Brugg, B
    Michel, PP
    Hunot, S
    Faucheux, B
    Hirsch, E
    Agid, Y
    JOURNAL OF NEUROCHEMISTRY, 1997, 69 : S140 - S140
  • [27] The Role of Ceruloplasmin in Neurodegeneration in Parkinson's Disease
    Gurer, Reyhan
    Aydin, Senay
    Gokce, Dilvin
    Ayaz, Tunahan
    Isik, Nihal
    TURKISH JOURNAL OF NEUROLOGY, 2016, 22 (01) : 19 - 25
  • [28] Neurodegeneration and Neuroregeneration in Experimental Parkinson's Disease
    Blandini, F.
    Cova, L.
    Armentero, M. -T.
    Bossolasco, P.
    Polli, E.
    Nappi, G.
    Silani, V.
    CELL TRANSPLANTATION, 2010, 19 (03) : 332 - 333
  • [29] CSF markers of neurodegeneration in Parkinson's disease
    Vranova, Hana Prikrylova
    Mares, Jan
    Nevrly, Martin
    Stejskal, David
    Zapletalova, Jana
    Hlustik, Petr
    Kanovsky, Petr
    JOURNAL OF NEURAL TRANSMISSION, 2010, 117 (10) : 1177 - 1181
  • [30] Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease
    Gelders, Geraldine
    Baekelandt, Veerle
    Van der Perren, Anke
    JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018
12345